MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Wednesday, June 7, 2017

1:15pm-2:45pm
The Corticobasal Degeneration Functional Rating Scale (CBD-FS)

A. Lang, G. Stebbins, A. Boxer (Toronto, Canada)

Rating Scales  ·  Exhibit Hall C
1:15pm-2:45pm
The diagnostic dilemma of olivopontocerebellar atrophy and spinocerebellar ataxia, a comparative analysis of clinical cases.

S. Gazieva, O. Turgunkhujaev (Tashkent, Uzbekistan)

Ataxia  ·  Exhibit Hall C
1:15pm-2:45pm
The Effect of Anxiety on Cognition in Parkinson’s Disease

S. Anderson, G. Stebbins, B. Bernard, A. Negron, J. Goldman (Chicago, IL, USA)

Parkinson's Disease: Cognition  ·  Exhibit Hall C
1:15pm-2:45pm
The Effects of Contingency-based Musical Gait Feedback on Cognition in Individuals with Parkinson’s disease: An Interim Analysis

J. Burt, E. Ravid, S. Bradford, N. Fisher, Y. Zeng, B. Hu, R. Camicioli (Edmonton, AB, Canada)

Parkinson's Disease: Cognition  ·  Exhibit Hall C
1:15pm-2:45pm
The efficacy of continuous apomorphine infusion in advanced PD patients with cognitive impairments

R. Borgemeester, T. van Laar (Groningen, Netherlands)

Neuropharmacology  ·  Exhibit Hall C
1:15pm-2:45pm
The French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD): Translation and validation in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD).

G. Hipp, M. Vaillant, M. Gantenbein, M. Kerschenmeyer, P. Kolber, C. Stallinger, K. Roomp, L. Longhino, A. Schweicher, R. Krüger, J. Simons (Belvaux, Luxembourg)

Rating Scales  ·  Exhibit Hall C
1:15pm-2:45pm
The hardest symptoms that bother patients with Parkinson’s disease

V. Vuletic (Rijeka, Croatia)

Phenomenology and Clinical Assessment Of Movement Disorders  ·  Exhibit Hall C
1:15pm-2:45pm
The highly-selective metabotropic glutamate receptor 2 positive allosteric modulator LY-487,379 alleviates psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset

L. Sid-Otmane, S. Nuara, A. Hamadjida, N. Veyres, C. Rouillard, M. Panisset, J. Gourdon, P. Huot (Montreal, QC, Canada)

Neuropharmacology  ·  Exhibit Hall C
1:15pm-2:45pm
The highly-selective mGluR2 positive allosteric modulator LY-487,379 alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease

C. Kwan, I. Frouni, V. Nafade, D. Gagnon, M.-J. Wallman, L. Sid-Otmane, M. Parent, A. Parent, C. Rouillard, H. Adjia, P. Huot (Montreal, QC, Canada)

Neuropharmacology  ·  Exhibit Hall C
1:15pm-2:45pm
The identification of molecular-genetic background of familial atypical parkinsonism in “Hornacko”, a specific region of the south-eastern Moravia, Czech Republic.

K. Mensikova, R. Vodicka, K. Kolarikova, T. Bartonikova, P. Kanovsky (Olomouc, Czech Republic)

Parkinson's Disease: Genetics  ·  Exhibit Hall C